Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 9 EP applications Heloise West has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13709884

INFLUENZA VACCINES

IPC classification:
A61K 39/145
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Heloise West, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11709973

HIV VACCINE

IPC classification:
A61K 39/21, A61P 31/18
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Heloise West, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11763641

VACCINE

IPC classification:
A61K 39/21
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Heloise West, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11799673

MYCOBACTERIUM ANTIGENIC COMPOSITION

IPC classification:
A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14728931

METHOD FOR DETERMINING THE ENDOTOXIN CONTENT OF AN ALUMINIUM SALT PREPARATION

IPC classification:
A61K 39/00, A61K 39/39, G01N 1/34, G01N 1/40, G01N 33/569, G01N 33/579
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Heloise West, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15201196

MYCOBACTERIUM ANTIGENIC COMPOSITION

IPC classification:
A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Heloise West, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14777272

NOVEL INFLUENZA ANTIGENS AND ANTIBODIES

IPC classification:
A61K 39/145, C07K 16/10
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Heloise West, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11794778

MYCOBACTERIUM ANTIGENIC COMPOSITION

IPC classification:
A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15197199

INFLUENZA VACCINE

IPC classification:
A61K 39/00, A61K 39/12, A61K 39/145, A61P 31/12, C07K 14/005, C12N 7/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
SmithKline Beecham Pharma GmbH & Co. KG
Agent:
Heloise West, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature